| Literature DB >> 26851769 |
Xingju Nie1, Danielle W Lowe2, Laura Grace Rollins3, Jessica Bentzley4, Jamie L Fraser5, Renee Martin6, Inderjit Singh7, Dorothea Jenkins8.
Abstract
Approximately half of moderate to severely hypoxic-ischemic (HI) newborns do not respond to hypothermia, the only proven neuroprotective treatment. N-acetylcysteine (NAC), an antioxidant and glutathione precursor, shows promise for neuroprotection in combination with hypothermia, mitigating post-HI neuroinflammation due to oxidative stress. As mechanisms of HI injury and cell death differ in males and females, sex differences must be considered in translational research of neuroprotection. We assessed the potential toxicity and efficacy of NAC in combination with hypothermia, in male and female neonatal rats after severe HI injury. NAC 50mg/kg/d administered 1h after initiation of hypothermia significantly decreased iNOS expression and caspase 3 activation in the injured hemisphere versus hypothermia alone. However, only females treated with hypothermia +NAC 50mg/kg showed improvement in short-term infarct volumes compared with saline treated animals. Hypothermia alone had no effect in this severe model. When NAC was continued for 6 weeks, significant improvement in long-term neuromotor outcomes over hypothermia treatment alone was observed, controlling for sex. Antioxidants may provide insufficient neuroprotection after HI for neonatal males in the short term, while long-term therapy may benefit both sexes.Entities:
Keywords: N-acetylcysteine; Neonatal hypoxia ischemia; Neuroprotection; Redox regulation; Sex
Mesh:
Substances:
Year: 2016 PMID: 26851769 PMCID: PMC4903952 DOI: 10.1016/j.neures.2016.01.008
Source DB: PubMed Journal: Neurosci Res ISSN: 0168-0102 Impact factor: 3.304